1. Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis

   • Shruti Bhandari
   • Rohit Kumar
   • Rebecca Redman

   Short Communication 16 September 2019 Article: 90

   

2. Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer

   • Mayuko Ito
   • Yoshiya Horimoto
   • Mitsue Saito

   Short Communication 13 September 2019 Article: 89

   

3. Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers

   • Osamu Soma
   • Shingo Hatakeyama
   • Chikara Ohyama

   Original Paper 13 September 2019 Article: 88

   

4. Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience

   • Justin C. Tossey
   • Joshua Reardon
   • Matthew J. Arango

   Original Paper 07 September 2019 Article: 87

   

5. Circular RNA expression and circPTPRM promotes proliferation and migration in hepatocellular carcinoma

   • Zhun Luo
   • Xuelan Mao
   • Wei Cui

   Original Paper 07 September 2019 Article: 86

   

6. Outcomes in patients ≥ 80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancy

   • A. R. Lewis
   • C. Cipriano
   • M. G. McNamara

   Original Paper 06 September 2019 Article: 85

   

7. Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy

   • Feng Cui
   • Di Qu
   • Kejun Nan

   Original Paper 06 September 2019 Article: 84

   

8. Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment

   • Angelica Petrillo
   • Annalisa Pappalardo
   • Ferdinando De Vita

   Original Paper 23 August 2019 Article: 83